Company

Transforming global cancer care and research

Flatiron Health UK transforms real-world cancer data into powerful insights that improve outcomes for patients in the UK and around the world.

What we do

Flatiron Health is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, we provide technology and services to support patient care and make every person’s story count.

Our mission is to improve and extend lives by learning from the experience of every person with cancer.

Our vision is to improve cancer outcomes and care using cancer data.

a photo of two Flatiron UK employees having a conversation while looking at a tablet screen

About Flatiron Health UK

a photo of two Flatiron UK employees brainstorming at a whiteboard

Flatiron Health UK brings together the best minds in medicine and technology to transform how cancer is researched and treated. Today, the experiences of only a small percentage of cancer patients are represented in the clinical trials that currently form the evidence base for most treatment, drug development and regulatory decisions.

Flatiron Health UK helps to fill this gap by transforming information from electronic health records into high-quality real-world evidence (RWE) that helps address new and previously hard to answer questions.

Flatiron Health was founded in 2012

Since then, Flatiron data in the United States have:

supported meaningful insights relevant to a global cancer population

been featured in hundreds of peer-reviewed publications

informed decisions by regulators and health technology appraisal (HTA) bodies around the world

generated insights that helped expand treatment alternatives for patients with many different types of cancer, including men and women with breast cancer

illuminated the impact of U.S. healthcare policy on racial disparities in time to treatment

supported post-approval regulatory decision-making in ways that directly impact patient care, such as reducing the frequency of treatment visits from weekly to fortnightly

Learn more about Flatiron's business in the United States

Our leadership team

Dr. Blythe Adamson
Head of Outcomes Research and Evidence Generation, International
Lauren Brown
Head of Product, International
Finn Dierks
Senior Director, Legal
Adam Manhi
Country Lead, UK
Matt Murchison
Head of Engineering, International
Amit Samani, PhD
Medical Director
Dr. Kathi Seidl-Rathkopf
Data Insights Lead, International
Arun Sujenthiran, FRCS, MD(Res)
Clinical Lead and Senior Medical Director, Caldicott Guardian